Literature DB >> 8845449

Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis.

A M Friedlander1, S L Welkos, P L Worsham, G P Andrews, D G Heath, G W Anderson, M L Pitt, J Estep, K Davis.   

Abstract

Yersinia pestis, the causative agent of plague, possesses multiple virulence determinants encoded on its three plasmids and on its chromosome. We evaluated the role of the protein capsule F1 in virulence an immunity against plague. Strains lacking F1, either those that are naturally occurring or those with genetically defined nonpolar mutations in the structural gene, retained their virulence for mice and nonhuman primates. However, both active immunization with F1, from either a recombinant vector or Y. pestis, and passive immunization with F1 monoclonal antibody protected mice from experimental infection with wild-type F1-positive organisms. These results suggest that protective immunogens like F1 need not be essential for virulence. The rare isolation of virulent F1-negative organisms from F1-immunized animals infected with F1-positive strains supports this conclusion and also suggests that, in addition to F1, an optimal vaccine against plague should include essential virulence factors as immunogens.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8845449     DOI: 10.1093/clinids/21.supplement_2.s178

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  55 in total

1.  Yersinia pestis pFra shows biovar-specific differences and recent common ancestry with a Salmonella enterica serovar Typhi plasmid.

Authors:  M B Prentice; K D James; J Parkhill; S G Baker; K Stevens; M N Simmonds; K L Mungall; C Churcher; P C Oyston; R W Titball; B W Wren; J Wain; D Pickard; T T Hien; J J Farrar; G Dougan
Journal:  J Bacteriol       Date:  2001-04       Impact factor: 3.490

2.  Development of a vaccinia virus based reservoir-targeted vaccine against Yersinia pestis.

Authors:  Debaditya Bhattacharya; Joan Mecsas; Linden T Hu
Journal:  Vaccine       Date:  2010-09-25       Impact factor: 3.641

3.  Pleiotropic effects of the lpxM mutation in Yersinia pestis resulting in modification of the biosynthesis of major immunoreactive antigens.

Authors:  V A Feodorova; L N Pan'kina; E P Savostina; O S Kuznetsov; N P Konnov; L V Sayapina; S V Dentovskaya; R Z Shaikhutdinova; S A Ageev; B Lindner; A N Kondakova; O V Bystrova; N A Kocharova; S N Senchenkova; O Holst; G B Pier; Y A Knirel; A P Anisimov; V L Motin
Journal:  Vaccine       Date:  2009-02-13       Impact factor: 3.641

4.  Differential influence of the two Bacillus anthracis plasmids on regulation of virulence gene expression.

Authors:  A Fouet; M Mock
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

5.  Yersinia pestis IS1541 transposition provides for escape from plague immunity.

Authors:  Claire A Cornelius; Lauriane E Quenee; Derek Elli; Nancy A Ciletti; Olaf Schneewind
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

Review 6.  Intraspecific diversity of Yersinia pestis.

Authors:  Andrey P Anisimov; Luther E Lindler; Gerald B Pier
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

7.  Yersinia pestis with regulated delayed attenuation as a vaccine candidate to induce protective immunity against plague.

Authors:  Wei Sun; Kenneth L Roland; Xiaoying Kuang; Christine G Branger; Roy Curtiss
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

8.  Yersinia pestis caf1 variants and the limits of plague vaccine protection.

Authors:  Lauriane E Quenee; Claire A Cornelius; Nancy A Ciletti; Derek Elli; Olaf Schneewind
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

9.  Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis.

Authors:  P S G Chain; E Carniel; F W Larimer; J Lamerdin; P O Stoutland; W M Regala; A M Georgescu; L M Vergez; M L Land; V L Motin; R R Brubaker; J Fowler; J Hinnebusch; M Marceau; C Medigue; M Simonet; V Chenal-Francisque; B Souza; D Dacheux; J M Elliott; A Derbise; L J Hauser; E Garcia
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-09       Impact factor: 11.205

10.  In vitro intracellular trafficking of virulence antigen during infection by Yersinia pestis.

Authors:  Tracy L DiMezzo; Gordon Ruthel; Ernst E Brueggemann; Harry B Hines; Wilson J Ribot; Carol E Chapman; Bradford S Powell; Susan L Welkos
Journal:  PLoS One       Date:  2009-07-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.